Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medipal Holdings's Total Liabilities for the quarter that ended in Mar. 2026 was €6,141 Mil.
Medipal Holdings's quarterly Total Liabilities
increased
from Sep. 2025 (€6,577.34 Mil) to Dec. 2025 (€6,766.95 Mil) but then
declined
from Dec. 2025 (€6,766.95 Mil) to Mar. 2026 (€6,141.26 Mil).
Medipal Holdings's annual Total Liabilities
increased
from Mar. 2024 (€6,524.65 Mil) to Mar. 2025 (€6,621.66 Mil) but then
declined
from Mar. 2025 (€6,621.66 Mil) to Mar. 2026 (€6,141.26 Mil).
Medipal Holdings Total Liabilities Related Terms
Medipal Holdings Total Liabilities Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Medipal Holdings's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings (FRA:59Z) has a Total Liabilities of €6,141 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Medipal Holdings and its competitors.
Is Medipal Holdings' Total Liabilities too high?
Medipal Holdings' current Total Liabilities is €6,141 Mil. Overall, Medipal Holdings has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Total Liabilities compare to MCK and COR?
Medipal Holdings' Total Liabilities of €6,141 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Distribution company?
A good Total Liabilities depends on the Medical Distribution industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Medipal Holdings and its competitors. Medipal Holdings's current Total Liabilities is €6,141 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Medipal Holdings (FRA:59Z) has a current Total Liabilities of €6,141 Mil. The stock's GF Value™ is €14.55, compared to a current price of €15.70 — trading 7.9% above its estimated fair value. The current Total Liabilities is €6,141 Mil. Medipal Holdings' overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Medipal Holdings (FRA:59Z), the current Total Liabilities is €6,141 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (FRA:59Z) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued.
The current stock price of €15.70 is trading 7.9% above its estimated GF Value™ of €14.55.
Key valuation signals for FRA:59Z:
Total Liabilities: €6,141 Mil
GF Value™: €14.55 vs. price of €15.70 (7.9% above fair value)
No single metric tells the full story. See the FRA:59Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
82GF Score
Get the complete analysis for FRA:59Z
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:59Z has been successfully added to your 
